CASI Pharmaceuticals (NASDAQ:CASI) reported third quarter 2025 results for the period ended...
Pharmaceuticals
TEL AVIV, Israel, May 22, 2025 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical...
March 31, 2025 4:00 PM EDT | Source: Phio Pharmaceuticals Corp. Continues advancing clinical trial for INSTASYL siRNA lead...
Salarius Pharmaceuticals, Inc. Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development...
